BioMarin Pharmaceuticals BMRN Amortization of capitalized software and acquired intangible assets
Amortization of capitalized software and acquired intangible assets at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's amortization of capitalized software and acquired intangible assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
- BioMarin Pharmaceuticals (BMRN) reported amortization of capitalized software and acquired intangible assets of $4.48M in Q1 2026.
- How has BioMarin Pharmaceuticals's amortization of capitalized software and acquired intangible assets changed year-over-year?
- BioMarin Pharmaceuticals's amortization of capitalized software and acquired intangible assets decreased by 7.5% year-over-year, from $4.85M to $4.48M.
- What is the long-term trend for BioMarin Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
- Over 3 years (2022 to 2025), BioMarin Pharmaceuticals's amortization of capitalized software and acquired intangible assets has grown at a -33.9% compound annual growth rate (CAGR), from $67.19M to $19.39M.